Environmental impact of traditional medicines in pharmaceutical manufacturing: Using a life cycle assessment

Authors

  • Widya Motivasi Manurung Department of Environmental Science, Graduate School of Sustainable Development, Universitas Indonesia, Jakarta, Central Jakarta 10440, Indonesia
  • Haruki Agustina Department of Environmental Science, Graduate School of Sustainable Development, Universitas Indonesia, Jakarta, Central Jakarta 10440, Indonesia
  • Ahyahudin Sodri Department of Environmental Science, Graduate School of Sustainable Development, Universitas Indonesia, Jakarta, Central Jakarta 10440, Indonesia

DOI:

https://doi.org/10.61511/phraj.v4i1.2026.3812

Keywords:

environmental impact, pharmaceutical manufacturing, life cycle assessment

Abstract

Background: The production of pharmaceutical products requires significant amounts of energy, raw materials, and chemical inputs, which may result in greenhouse gas emissions and other environmental burdens throughout the product life cycle. The manufacture of traditional medicines, which utilize natural resources such as herbal materials, likewise involves energy-intensive processes that may contribute to environmental degradation. This study aims to assess the environmental impacts associated with the production of traditional herbal cough medicines and compare them with non-herbal cough medicines and to identify critical points that contribute to greenhouse gas emissions. Methode: This study adopts a quantitative approach employing the Life Cycle Assessment (LCA) methodology in accordance with the ISO 14040 standard. The system boundary is defined as cradle-to-gate. The functional unit is defined as one metric ton of packaged traditional medicine products. Environmental impact assessment is conducted using the IPCC 2021 GWP100 V1.00 method through SimaPro 10.2.0.3 software, supported by the Ecoinvent 3.0 database. The analysis focuses on the Global Warming Potential (GWP) indicator. Findings: The results indicate that the production of traditional herbal cough medicines generates total emissions of approximately 47,5 tCO₂-eq per one metric ton, whereas the manufacture of non-herbal cough medicines produces a higher total of approximately 105,98 tCO₂-eq. Across both production systems, several utility processes were identified as contributing significantly to environmental impacts. In particular, HVAC system was identified as a critical hotspot, accounting for approximately 21.86% of total emissions due to its substantial electricity consumption, equivalent to 3,5 tCO₂-eq per one metric ton product. Conclusion: The life cycle assessment conducted for the production of non-herbal indicates generate higher CO₂ emissions compared to herbal products. Novelty/Originality of this article: This study compares the environmental impacts associated with the production processes of traditional herbal cough medicines and non-herbal cough medicines using the Life Cycle Assessment methodology.

References

Beck, A., Wiedergut, M., & Neubauer, N. (2025). Towards fossil-free energy supply: Cost-effective decarbonization measures in pharmaceutical energy systems. Applied Thermal Engineering, 280, 128213. https://doi.org/10.1016/j.applthermaleng.2025.128213

Brodin, T., Nordling, J., Lagesson, A., Klaminder, J., Hellström, G., Christensen, B., & Fick, J. (2017). Environmental relevant levels of a benzodiazepine (oxazepam) alters important behavioral traits in a common planktivorous fish (Rutilus rutilus). Journal of Toxicology and Environmental Health, Part A, 80(16–18), 963–970. https://doi.org/10.1080/15287394.2017.1352214

Chaturvedi, P., Shukla, P., Giri, B. S., Chowdhary, P., Chandra, R., Gupta, P., & Pandey, A. (2021). Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants. Environmental Research, 194, 110664. https://doi.org/10.1016/j.envres.2020.110664

Cheng, X., Li, C., Ma, X., & Shao, X. (2022). Differential pressure control method for pharmaceutical cleanrooms under variable air supply conditions. Building and Environment, 213, 108849. https://doi.org/10.1016/j.buildenv.2022.108849

Goodman, M. (2009). Pharmaceutical industry financial performance. Nature Reviews Drug Discovery, 8(12), 927–928. https://doi.org/10.1038/nrd3049

Groen, E. A., Bokkers, E. A. M., Heijungs, R., & de Boer, I. J. M. (2017). Methods for global sensitivity analysis in life cycle assessment. The International Journal of Life Cycle Assessment, 22, 1125–1137. https://doi.org/10.1007/s11367-016-1217-3

Hagenaars, R. H., Heijungs, R., de Koning, A., Tukker, A., & Wang, R. (2025). The greenhouse gas emissions of pharmaceutical consumption and production: An input–output analysis over time and across global supply chains. The Lancet Planetary Health, 9(3), e196–e206. https://doi.org/10.1016/S2542-5196(25)00028-2

International Organization for Standardization. (2006). ISO 14040: Environmental management—Life cycle assessment—Principles and framework. ISO. https://www.iso.org/standard/37456.html

Jobling, S., Williams, R., Johnson, A., Taylor, A., Gross-Sorokin, M., Nolan, M., Tyler, C. R., van Aerle, R., Santos, E., & Brighty, G. (2006). Predicted exposures to steroid estrogens in UK rivers correlate with widespread sexual disruption in wild fish populations. Environmental Health Perspectives, 114(Suppl 1), 32–39. https://doi.org/10.1289/ehp.8050

Laurent, A., Weidema, B. P., Bare, J., Liao, X., de Souza, D. M., Pizzol, M., Sala, S., Schreiber, H., Thonemann, N., & Verones, F. (2020). Methodological review and detailed guidance for the life cycle interpretation phase. Journal of Industrial Ecology, 24(5), 986–1003. https://doi.org/10.1111/jiec.13012

Liu, J., Hull, V., Godfray, H. C. J., Tilman, D., Gleick, P., Hoff, H., Pahl-Wostl, C., Xu, Z., Chung, M. G., Sun, J., & Li, S. (2018). Nexus approaches to global sustainable development. Nature Sustainability, 1(9), 466–476. https://doi.org/10.1038/s41893-018-0135-8

Liu, J., Zhang, L., Yang, J., Chen, Y., & Zhang, X. (2021). Study on pressure control and energy saving of cleanroom in purification air conditioning system. Energy and Buildings, 253, 111502. https://doi.org/10.1016/j.enbuild.2021.111502

Marsit, N. M., Saadawi, S., & Alennabi, K. (2025). Challenges of growth-based microbiological methods in sterility assurance of pharmaceutical product manufacturing. Discover Pharmaceutical Sciences, 1, 13. https://doi.org/10.1007/s44395-025-00020-6

Massoud, M. A., Makarem, N., Ramadan, W., & Nakkash, R. (2015). Environmental management practices in the Lebanese pharmaceutical industries: Implementation strategies and challenges. Environmental Monitoring and Assessment, 187(3), 107. https://doi.org/10.1007/s10661-015-4290-3

Oaks, J. L., Gilbert, M., Virani, M. Z., Watson, R. T., Meteyer, C. U., Rideout, B. A., Shivaprasad, H. L., Ahmed, S., Chaudhry, M. J. I., Arshad, M., Mahmood, S., Ali, A., & Khan, A. A. (2004). Diclofenac residues as the cause of vulture population decline in Pakistan. Nature, 427(6975), 630–633. https://doi.org/10.1038/nature02317

Ministry of Industry of the Republic of Indonesia. (2022). Manufacturing industry largely contributes to economic growth in Q2 this year. Sekretariat Kabinet Republik Indonesia. https://setkab.go.id/en/manufacturing-industry-largely-contributes-to-economic-growth-in-q2-this-year/

Okeke, E. S., Ezeorba, T. P. C., Okoye, C. O., Chen, Y., Mao, G., Feng, W., & Wu, X. (2022). Environmental and health impact of unrecovered API from pharmaceutical manufacturing wastes: A review of contemporary treatment, recycling and management strategies. Sustainable Chemistry and Pharmacy, 30, 100865. https://doi.org/10.1016/j.scp.2022.100865

Parker, G., & Miller, F. A. (2024). Tackling Pharmaceutical Pollution Along the Product Lifecycle: Roles and Responsibilities for Producers, Regulators and Prescribers. Pharmacy, 12(6), 173. https://doi.org/10.3390/pharmacy12060173

Parvatker, A. G., Tunceroglu, H., Sherman, J. D., Coish, P., Anastas, P. T., Zimmerman, J. B., & Eckelman, M. J. (2019). Cradle-to-gate greenhouse gas emissions for twenty anesthetic active pharmaceutical ingredients based on process scale-up and process design calculations. ACS Sustainable Chemistry & Engineering, 7(7), 6580–6591. https://doi.org/10.1021/acssuschemeng.8b05473

Patel, M., Kumar, R., Kishor, K., Mlsna, T., Pittman, C. U., Jr., & Mohan, D. (2019). Pharmaceuticals of emerging concern in aquatic systems: Chemistry, occurrence, effects, and removal methods. Chemical Reviews, 119(6), 3510–3673. https://doi.org/10.1021/acs.chemrev.8b00299

Riikonen, S., Timonen, J., & Sikanen, T. (2024). Environmental considerations along the life cycle of pharmaceuticals: Interview study on views regarding environmental challenges, concerns, strategies, and prospects within the pharmaceutical industry. European Journal of Pharmaceutical Sciences, 196, 106743. https://doi.org/10.1016/j.ejps.2024.106743

Sanyé-Mengual, E., Valente, A., Biganzoli, F., et al. (2022). Linking inventories and impact assessment models for addressing biodiversity impacts: Mapping rules and challenges. The International Journal of Life Cycle Assessment, 27, 813–833. https://doi.org/10.1007/s11367-022-02049-6

Siegert, M.-W., Finkbeiner, M., Emara, Y., & Lehmann, A. (2019). Product category rules (PCR) for pharmaceutical products and processes. Institute of Environmental Technology (Technischen Umweltschutz). https://doi.org/10.14279/depositonce-9143

Steubing, B., Mutel, C., Suter, F., & Hellweg, S. (2016). Streamlining scenario analysis and optimization of key choices in value chains using a modular LCA approach. The International Journal of Life Cycle Assessment, 21(4), 510–522. https://doi.org/10.1007/s11367-015-1015-3

Tomažič, S., & Škrjanc, I. (2025). Advanced model predictive control strategies for energy-efficient HVAC systems in pharmaceutical facilities. Energy and Buildings, 347, 116348. https://doi.org/10.1016/j.enbuild.2025.116348

Wernet, G., Conradt, S., Isenring, H. P., Jiménez-González, C., & Hungerbühler, K. (2010). Life cycle assessment of fine chemical production: A case study of pharmaceutical synthesis. The International Journal of Life Cycle Assessment, 15(3), 294–303. https://doi.org/10.1007/s11367-010-0151-z

Wiesen, K., & Wirges, M. (2017). From cumulated energy demand to cumulated raw material demand: The material footprint as a sum parameter in life cycle assessment. Energy, Sustainability and Society, 7, 13. https://doi.org/10.1186/s13705-017-0115-2

World Bank. (2023). World Bank annual report 2023: A new era in development. World Bank. https://documents1.worldbank.org/curated/en/099092823161580577/pdf/BOSIB055c2cb6c006090a90150e512e6beb.pdf

Zhang, Y., Wang, Y., Zhang, J., Liu, J., Ruan, J., Jin, X., Liu, D., Lu, Z., & Xu, Z. (2024). Research on waste gas treatment technology and comprehensive environmental performance evaluation for collaborative management of pollution and carbon in China’s pharmaceutical industry based on life cycle assessment (LCA). Science of the Total Environment, 919, 170555. https://doi.org/10.1016/j.scitotenv.2024.170555

Zhao, X., Tang, Y., Tian, X., He, M., Li, X., Peng, Y., Li, L., & Zhang, S. (2025). Improved mathematical model simulates methane production during anaerobic digestion of food waste under stable and unstable acidification conditions. Journal of Environmental Chemical Engineering, 13, 115833. https://doi.org/10.1016/j.jece.2025.115833

Downloads

Published

2026-07-31

How to Cite

Manurung, W. M., Agustina, H., & Sodri, A. (2026). Environmental impact of traditional medicines in pharmaceutical manufacturing: Using a life cycle assessment. Public Health Risk Assesment Journal, 4(1), 36–57. https://doi.org/10.61511/phraj.v4i1.2026.3812

Issue

Section

Articles

Citation Check